Cristina Bucelli

Circulating Levels of PF4/CXCL4 in Patients With BCR: :ABL1 ‐Negative Myeloproliferative Neoplasms: A New Potential Prognostic Factor for Disease Progression

Valentina Bellani, Daniele Cattaneo, Vittorio Abbonante, Cristina Bucelli et autres

it, us (code pays fourni par la source)

Correction: Proteomic screening identifies PF4/Cxcl4 as a critical driver of myelofibrosis

Daniele Capitanio, Francesca Rossella Calledda, Vittorio Abbonante, Daniele Cattaneo et autres

it, us (code pays fourni par la source)

Bone Marrow CD34+/lin− Cells of Patients with Chronic-Phase Chronic Myeloid Leukemia (CP-CML) After 12 Months of Nilotinib Treatment Exhibit a Different Gene Expression Signature Compared to the Diagnosis and the Corresponding Cells from Healthy Subjects

Alessandra Trojani, Ester Pungolino, Barbara Di Camillo, Luca Emanuele Bossi et autres

it (code pays fourni par la source)

Digital PCR (dPCR) is able to anticipate the achievement of stable deep molecular response in adult chronic myeloid leukemia patients: results of the DEMONSTRATE study

Simona Bernardi, Alessia Cavalleri, Silvia Mutti, Luca Garuffo et autres

it (code pays fourni par la source)

Baseline Features, Treatment Choice and Early Frontline TKI Permanent Discontinuation in Patients with Newly Diagnosed Chronic Myeloid Leukemia Aged 50 - 60 Years: A “Campus CML” Study

Roberto Latagliata, Isabella Capodanno, Maria Cristina Miggiano, Cristina Bucelli et autres

it, my (code pays fourni par la source)

Assessment of Transitioning from High-Potency to Low-Potency Inhibitors in Chronic Myeloid Leukemia (CML) Patients: The Downgrading-Impact Project, a CML Campus Study

Elisabetta Abruzzese, Simona Bernardi, Uroš Markovic, Malgorzata Monika Trawinska et autres

it, ch (code pays fourni par la source)

Prognostic Insights on PRE-Fibrotic Primary Myelofibrosis: A Clinical-Pathological Perspective in 762 Patients

Daniele Cattaneo, Bárbara Mora, Cristina Bucelli, Margherita Maffioli et autres

it (code pays fourni par la source)

Association of Hypometilating Agents + Venetoclax in the Treatment of Secondary Acute Myeloid Leukemias Evolved from Chronic Myelomonocytic Leukemia

Francesco Onida, Antonella Bruzzese, Fabrizio Cavalca, Benedetta Cambò et autres

it (code pays fourni par la source)

A-149 For something completely different: granuloma annulare-like histiocytosis as skin specific manifestation of ETV6::SYK rearranged myeloid neoplasm with eosinophilia

Giorgio Alberto Croci, Silvia Tabano, Carlo Alberto Maronese, Angelo Valerio Marzano et autres

Bosutinib Treatment of Chronic Myeloid Leukemia in Lombardy

Alessandra Iurlo, Cristina Bucelli, Tamara Intermesoli, Chiara Elena et autres

it (code pays fourni par la source)

Choice of Frontline Tyrosine‐Kinase Inhibitor and Early Events in Very Elderly Patients With Chronic Myeloid Leukemia in Chronic Phase: A “Campus CML ” Study

Cristina Bucelli, Isabella Capodanno, Maria Cristina Miggiano, Francesco Cavazzini et autres

it (code pays fourni par la source)

Treatment‐free remission as a new goal in the management of chronic myeloid leukemia: Clinical and biological aspects

Daniele Cattaneo, Cristina Bucelli, Valentina Bellani, Bárbara Mora et autres

it (code pays fourni par la source)